Home · Health · Sep 24 archive
Trump's FDA Pick Overton Faces Senate Hearing
Confirmed
In Short: Heidi Overton, President Donald Trump's pick to lead the Food and Drug Administration (FDA), will face a confirmation hearing before the Senate health committee on Thursday.
Heidi Overton, President Donald Trump's pick to lead the Food and Drug Administration (FDA), will face a confirmation hearing before the Senate health committee on Thursday.
Overton, a 37-year-old preventive medicine physician and deputy director of the White House Domestic Policy Council, was nominated in August.
The hearing will scrutinize Overton's views on vaccines, the abortion pill, and her adherence to policies pushed by Health Secretary Alex Azar.
Overton's anti-abortion stance, which she has called a 'huge victory for life,' is expected to draw significant Democratic opposition and scrutiny.
The FDA, currently facing staff losses and morale issues, has seen more than 3,000 employees leave over the past year.
Overton's lack of managerial experience and her ties to conservative think tanks like the America First Policy Institute may also be questioned.
Senator Bill Cassidy, the Republican chairman of the committee and a physician, is likely to press Overton on vaccines and her independence from Azar.
To become FDA commissioner, Overton needs a majority vote from the 21-member health committee, followed by a positive vote from the full Senate.
Overton's nomination coincides with new initiatives from Trump health officials on autism, vaccines, and the abortion pill.
Her confirmation would make her the youngest FDA commissioner ever, and she would oversee the ongoing FDA review of mifepristone, the leading abortion pill.
Overton's work on White House health initiatives, including the revamped food pyramid and efforts to overhaul childhood vaccines, may also come under review.
What this adds
Overton's nomination highlights the ongoing political tensions surrounding the FDA's role in public health and reproductive rights.
What's confirmed
- Heidi Overton, President Donald Trump's pick to lead the Food and Drug Administration (FDA), will face a confirmation hearing before the Senate health committee on Thursday.
- Overton, a 37-year-old preventive medicine physician and deputy director of the White House Domestic Policy Council, was nominated in August.
- The hearing will scrutinize Overton's views on vaccines, the abortion pill, and her adherence to policies pushed by Health Secretary Alex Azar.
- Overton's anti-abortion stance, which she has called a 'huge victory for life,' is expected to draw significant Democratic opposition and scrutiny.
- The FDA, currently facing staff losses and morale issues, has seen more than 3,000 employees leave over the past year.
- Overton's lack of managerial experience and her ties to conservative think tanks like the America First Policy Institute may also be questioned.
- Senator Bill Cassidy, the Republican chairman of the committee and a physician, is likely to press Overton on vaccines and her independence from Azar.
- To become FDA commissioner, Overton needs a majority vote from the 21-member health committee, followed by a positive vote from the full Senate.
- Overton's nomination coincides with new initiatives from Trump health officials on autism, vaccines, and the abortion pill.
- Her confirmation would make her the youngest FDA commissioner ever, and she would oversee the ongoing FDA review of mifepristone, the leading abortion pill.
- Overton's work on White House health initiatives, including the revamped food pyramid and efforts to overhaul childhood vaccines, may also come under review.
What's still developing
- That question has become a fixture of recent confirmation hearings for Trump health nominees.
- To read the rest of this story subscribe to STAT+.
- You may opt out of receiving STAT communications at any time.